Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/18/2003WO2003057851A3 Binding proteins as biosensors
09/18/2003WO2003057130A3 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
09/18/2003WO2003054164A3 C-type lectin polypeptide, polynucleotide and methods of making and use thereof
09/18/2003WO2003054015A3 Use of coagulant-active antitrhombin iii for the therapy of angiogenesis-dependent diseases
09/18/2003WO2003046135A3 Osteopontin-related compositions and methods
09/18/2003WO2003039454A8 Beta-secretase inhibitors and methods of use
09/18/2003WO2003037363A3 Non-neurotoxic plasminogen activating factors for treating stroke
09/18/2003WO2003035861A3 Thrombin-cleavable chimeric proteins
09/18/2003WO2003035105A3 A synthetic chimeric fusion protein with immuno-therapeutic uses
09/18/2003WO2003033808A3 Composition and method for treating diabetes
09/18/2003WO2003033736A3 Fine mapping and application of dna markers linked to a gall midge resistance gene for marker-aided selection in rice
09/18/2003WO2003033692A3 Use of the adenoviral e2 late promoter
09/18/2003WO2003031584A3 Axon repair
09/18/2003WO2003023013A3 Novel nucleic acids and polypeptides
09/18/2003WO2003022878A3 Subunit respiratory syncytial virus vaccine preparation
09/18/2003WO2003014347A3 Plant seed specific promoters
09/18/2003WO2003012113A3 Inducible expression systems employing ppar transcriptional activators
09/18/2003WO2003008441A3 Moringa seed proteins
09/18/2003WO2003006498A3 Oncosuppressive gene
09/18/2003WO2003004521A3 Nucleotide sequence and method for increasing the resistance to disease in plants
09/18/2003WO2002103015A3 Abca10 transporter
09/18/2003WO2002102411A3 Method for treating psoriasis by using an il-17d antagonist
09/18/2003WO2002100901A3 Determination of bone-sialoprotein in bodily fluids for oncological problems
09/18/2003WO2002097079A3 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene
09/18/2003WO2002094868A3 Staphylococcus aureus proteins and nucleic acids
09/18/2003WO2002077174A3 Human cytokine receptor
09/18/2003WO2002072790A3 Tsg101-gag interaction and use thereof
09/18/2003WO2002072614A3 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
09/18/2003WO2002072027A3 Oncolytic rna replicons
09/18/2003WO2002068455A3 Efficient recovery of correctly refolded proteins
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002064793A3 G protein-coupled receptor-like proteins and nucleics acids encoding same
09/18/2003WO2002064628A3 Isolated human transporter proteins nucleic acids and use thereof
09/18/2003WO2002060914A3 Identification of small rnas and orfs form e. coli as mediators of cell and intercell regulation
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003WO2002050287A3 Multifunctional protease inhibitors and their use in treatment of disease
09/18/2003WO2002042459A3 Position dependent recognition of gnn nucleotide triplets by zinc fingers
09/18/2003WO2002036625A9 Prokineticin polypeptides, related compositions and methods
09/18/2003WO2002032929A3 Haplotypes of the cer1 gene
09/18/2003WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
09/18/2003WO2002029056A3 Mini-dystrophin nucleic acid and peptide sequences
09/18/2003WO2002025284A3 High-throughput assays for the proteolytic activities of clostridial neurotoxins
09/18/2003WO2002014503A3 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies
09/18/2003WO2001098454A8 Human dna sequences
09/18/2003WO2001072956A3 Compounds and methods for modulating desmosomal cadherin-mediated functions
09/18/2003US20030177547 Imprinting in plants to control gene expression
09/18/2003US20030177537 Transgenic plant; genetic engineering
09/18/2003US20030177536 Transgenic plant; genetic engineering
09/18/2003US20030177535 Genes for altering mitochondrial function and for hybrid seed production
09/18/2003US20030177529 Transforming plant cell with expression vector
09/18/2003US20030177528 Genes encoding novel proteins with pesticidal activity against Coleopterans
09/18/2003US20030177527 Nucleotide sequences coding signal transduction components in durable and broad-range resistance strategies based on plant defence
09/18/2003US20030177526 Receptors for hypersensitive response elicitors and uses thereof
09/18/2003US20030177520 Transgenic plant; genetic engineering
09/18/2003US20030177513 Insertion genome; activation; generating embryo
09/18/2003US20030177511 Antitumor, anticancer agents
09/18/2003US20030177507 Transgenic animal model; determination variations in plaque deposits
09/18/2003US20030176784 Labeling targeting agents with gallium-68 and gallium-67
09/18/2003US20030176689 Inhibitors of hepatitis C virus protease
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176685 DNA encoding orphan SNORF7 receptor
09/18/2003US20030176683 Bone repair; animal extract in matrix
09/18/2003US20030176681 Antiarthritic agents; autoimmune diseases; antihistamines; Aids; psoriasis
09/18/2003US20030176680 High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
09/18/2003US20030176679 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds
09/18/2003US20030176678 Viricides, antitumor agents, antiproliferative agents, anticancer agents; genetic engineered Dna
09/18/2003US20030176676 Methods of treating vascular inflammatory pathologies using chimeric anti-TNF antibodies
09/18/2003US20030176675 TyrA genes and uses thereof
09/18/2003US20030176674 Vascular endothelial growth factor 2
09/18/2003US20030176673 Fermentation of fusion protein; genetic engineering
09/18/2003US20030176672 Compositions and methods relating to breast specific genes and proteins
09/18/2003US20030176671 Controlling cell differentiation, cell proliferation; transgenic plant, animal
09/18/2003US20030176667 Transfroming growth factor; drug design
09/18/2003US20030176666 Hypothalamus-specific polypeptides
09/18/2003US20030176665 Soluble complexes of target proteins and peptidyl prolyl isomerase chaperones and methods of making and using them
09/18/2003US20030176662 Blocking binding to hepatitis virus; therapy for infection; drug design using computers
09/18/2003US20030176661 Novel antibody with specificity for colon cancer
09/18/2003US20030176659 Adipocyte-specific protein homologs
09/18/2003US20030176658 Adipocyte-specific protein homologs
09/18/2003US20030176657 Binding to antibodies; wound healing agent; cell proliferation stimulant
09/18/2003US20030176656 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins
09/18/2003US20030176655 Genetic engineering; cardiovascular disorders
09/18/2003US20030176653 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/18/2003US20030176652 Human and mouse beta-defensins, antimicrobial peptides
09/18/2003US20030176651 Multiprotein-complex comprising a nmda receptor and uses thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176649 Genetic engineering; cardiovascular disorders; antiischemic agents; antitumor agents; vision disorders; antiarthritic agents
09/18/2003US20030176648 Ion channel
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030176646 Methods for Purifying Selected CEA Family Member Proteins
09/18/2003US20030176645 Polypeptides; lubricant of mouth cavity
09/18/2003US20030176644 Compositions and methods for molecular biology
09/18/2003US20030176640 SGIP peptides
09/18/2003US20030176639 Peptide-based compounds
09/18/2003US20030176638 Liquid phase complexing with a polymer
09/18/2003US20030176396 Hybrid organic-inorganic adsorbents
09/18/2003US20030176388 Fatty acid synthase mRNA binding protein
09/18/2003US20030176385 For modulating the expression of H-Ras, WNT-7B, acetylglucosaminyltransferase, voltage-gated K channel, IL-8, ion transport, Map3K8 and Thymidine kinase
09/18/2003US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
1 ... 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 ... 2916